Company intelligence / Profile preview

Astrasana

Zurich, Zurich, Switzerland

Ownership: Private
Development stage: Other

Overview

Astrasana is a Swiss-based medical cannabis company that operates as a vertically integrated group across Europe and Asia. The company focuses on the cultivation, production, and international distribution of high-quality medical cannabis products, including flowers, extracts, and oils. Astrasana provides pharmaceutical-grade cannabinoids to pharmacies, hospitals, and wholesalers, ensuring compliance with Good Manufacturing Practice (GMP) standards. With a strong presence in Switzerland and the Czech Republic, the company aims to bridge the gap between cannabis production and patient access to medical-grade treatments.

Therapeutic areas: PsychiatryNeurologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Astrasana.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astrasana.

Explore the full profile